Fabentech Biotech

Fabentech Biotech Overview

Company Headquarters: Lyon, US

Founded: 2009

Workforce: ~25

Company Working: Fabentech Biotech is a pharmaceutical company that develops and manufactures polyclonal antibody treatments. Its platform is safe, tested, and fully validated on polyclonal antibody technology for fighting high-priority biological agents that could threaten public health. It has many local, national, and international partners, namely the National Institutes of Health (UK), US Army, World Health Organization, and the European Defense Fund, who are supporting its biodefense product development. This is the only company in Europe that is able to produce biodefense solutions while adhering to the most strict international norms

Strategy

Fabentech Biotech is primarily focusing on R&D to develop technology-based solutions for biodefense. Its goal is the rapid development of medical countermeasures against different infectious diseases through its integrated R&D and proprietary manufacturing. Moreover, it is focusing on building collaboration and partnerships with research and academic institutes, investors, and public supporters to enable the rapid production and clinical trials of its biodefense products

Company Snapshot

25

Employees

2009

Founded

Lyon, US

Headquarters

SWOT Analysis

Strengths

Strong brand name
Strong pipeline of product candidates to address significant unmet medical needs
A company that is able to produce biodefense solutions despite strict norms in Europe

Weaknesses

Less presence in Middle East & Africa

Opportunities

Partnership and collaboration accelerating the development of its biodefence pipeline product
Investment in R&D facilities to develop innovative products

Threats

Regulatory policies
Development of highly innovative products for unmet medical needs through competitors

Key Developments

Date	Approach	Development
December 2021	Investment	Fabentech Biotech received funding of USD 10.02 million for its EPIC-CROWN-2 project from the European Commission. The funding has been invested in the development of a COVID-19 disease treatment product.
March 2021	Expansion	Fabentech Biotech opened a cutting-edge industrial biomanufacturing site at Saint-Priest in which it has invested USD 4.35 million and received funding of approximately USD 1.74 million. This site was opened to address the challenge of rapid and large-scale production on national territory.

Product Offering

Fabentech Biotech
- Biodefense Market

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.